TY - JOUR
T1 - Sleep difficulties, incident dementia and all-cause mortality among older adults across 8 years
T2 - Findings from the National Health and Aging Trends Study
AU - Robbins, Rebecca
AU - Weaver, Matthew D.
AU - Barger, Laura K.
AU - Wang, Wei
AU - Quan, Stuart F.
AU - Czeisler, Charles A.
N1 - Funding Information:
This work was supported by the NIH grant numbers: K01HL150339 (RR), R01OH011773 (MDW, LKB), P01AG009975 (CAC) and R56HL151637 (MDW).
Funding Information:
SQ serves as a consultant for Jazz Pharmaceuticals, Whispersom, Amerisleep and Best Doctors. RR has received consulting fees from Denihan Hospitality, Rituals Cosmetics, Deep, Wave Sleep, and SleepCycle. CAC reports grants to Brigham and Women’s Hopsital (BWH) from FAA, NHLBI, NIA, NIOSH, NASA and DOD; is/was a paid consultant for Emory University, Inselspital Bern, UCLA, Institute of Digital Media and Child Development, Klarman Family Foundation, Physician's Seal, Sleep Research Society Foundation, Tencent Holdings Ltd, Teva Pharma Australia and Vanda Pharmaceuticals Inc, in which CAC also holds an equity interest; received travel support from Bloomage International Investment Group, Inc., UK Biotechnology and Biological Sciences Research Council, Bouley Botanical, Dr. Stanley Ho Medical Development Foundation, European Biological Rhythms Society, German National Academy of Sciences (Leopoldina), National Safety Council, National Sleep Foundation, Stanford Medical School Alumni Association, Tencent Holdings Ltd and Vanda Pharmaceuticals Inc; receives research/education support through BWH from Cephalon, Mary Ann & Stanley Snider via Combined Jewish Philanthropies, Harmony Biosciences LLC, Jazz Pharmaceuticals PLC Inc, Johnson & Johnson, NeuroCare, Inc., Philips Respironics Inc/Philips Homecare Solutions, Regeneron Pharmaceuticals, Regional Home Care, Teva Pharmaceuticals Industries Ltd, Sanofi SA, Optum, ResMed, San Francisco Bar Pilots, Sanofi, Schneider, Simmons, Sysco, Philips and Vanda Pharmaceuticals; is/was an expert witness in legal cases, including those involving Advanced Power Technologies, Aegis Chemical Solutions LLC, Amtrak, Casper Sleep Inc, C&J Energy Services, Catapult Energy Services Group, LLC, Covenant Testing Technologies, LLC, Dallas Police Association, Enterprise Rent‐A‐Car, Espinal Trucking/Eagle Transport Group LLC/Steel Warehouse Inc, FedEx, Greyhound Lines Inc/Motor Coach Industries/FirstGroup America, PAR Electrical Contractors Inc, Product & Logistics Services LLC/Schlumberger Technology Corp/Gelco Fleet Trust, Puckett Emergency Medical Services LLC, Union Pacific Railroad and Vanda Pharmaceuticals; serves as the incumbent of an endowed professorship provided to Harvard University by Cephalon, Inc.; and receives royalties from McGraw Hill and Philips Respironics for the Actiwatch‐2 and Actiwatch Spectrum devices. CAC’s interests were reviewed and are managed by the Brigham and Women's Hospital and Mass General Brigham in accordance with their conflict of interest policies. MDW reports grants from NHLBI and the Brigham Research Institute, and personal fees from the National Sleep Foundation and the University of Pittsburgh, outside the submitted work. LKB reports grants from NIOSH and personal fees from the University of Pittsburgh, CurAegis, Casis, Puget Sound Pilots, and Boston Children’s Hospital, outside the submitted work.
Publisher Copyright:
© 2021 European Sleep Research Society.
PY - 2021/12
Y1 - 2021/12
N2 - Sleep difficulties have been implicated in the development and progression of dementia and in all-cause mortality. This study examines the relationship between sleep difficulties, incident dementia and all-cause mortality over 8 years of follow-up among a nationally representative sample of older (≥65 years) adults in the United States. We used data collected from the National Health and Aging Trends Study (NHATS) from 2011 to 2018, a prospective cohort study of Medicare beneficiaries. At baseline, the NHATS sample comprised 6,376 older adults who were representative of 32 million older adults. Respondents reported routine difficulty initiating sleep or difficulty falling back asleep “most nights” or “every night” in each study year. In each year, dementia was determined by either self-reported diagnosis or performance on immediate and delayed recall word and clock drawing tests, whereas all-cause mortality was determined by proxy. We conducted Cox proportional hazards modelling, adjusting for age, sex, marital status and chronic conditions. In models predicting all-cause mortality, we also controlled for dementia. Among respondents at baseline, 19% were 65–75 years of age, 71% identified as non-Hispanic white and 59% were female. Difficulty initiating sleep (hazard ratio [HR], 1.49; 95% confidence interval [CI],1.25–1.77), difficulty falling back asleep (HR, = 1.39; 95% CI,1.14–1.70) and concurrent sleep difficulties (HR, 1.58; 95% CI, 1.25–1.99) were associated with greater risk of dementia. Difficulty initiating sleep (HR, 1.44; 95% CI,1.20–1.72), difficulty falling back asleep (HR, 1.56; 95% CI,1.29–1.89), and concurrent sleep difficulties (HR, 1.80; 95% CI, 1.44–2.24) were associated with greater risk of all-cause mortality. Our findings demonstrate that reported difficulties are prospectively associated with an increased risk of dementia and all-cause mortality among older people.
AB - Sleep difficulties have been implicated in the development and progression of dementia and in all-cause mortality. This study examines the relationship between sleep difficulties, incident dementia and all-cause mortality over 8 years of follow-up among a nationally representative sample of older (≥65 years) adults in the United States. We used data collected from the National Health and Aging Trends Study (NHATS) from 2011 to 2018, a prospective cohort study of Medicare beneficiaries. At baseline, the NHATS sample comprised 6,376 older adults who were representative of 32 million older adults. Respondents reported routine difficulty initiating sleep or difficulty falling back asleep “most nights” or “every night” in each study year. In each year, dementia was determined by either self-reported diagnosis or performance on immediate and delayed recall word and clock drawing tests, whereas all-cause mortality was determined by proxy. We conducted Cox proportional hazards modelling, adjusting for age, sex, marital status and chronic conditions. In models predicting all-cause mortality, we also controlled for dementia. Among respondents at baseline, 19% were 65–75 years of age, 71% identified as non-Hispanic white and 59% were female. Difficulty initiating sleep (hazard ratio [HR], 1.49; 95% confidence interval [CI],1.25–1.77), difficulty falling back asleep (HR, = 1.39; 95% CI,1.14–1.70) and concurrent sleep difficulties (HR, 1.58; 95% CI, 1.25–1.99) were associated with greater risk of dementia. Difficulty initiating sleep (HR, 1.44; 95% CI,1.20–1.72), difficulty falling back asleep (HR, 1.56; 95% CI,1.29–1.89), and concurrent sleep difficulties (HR, 1.80; 95% CI, 1.44–2.24) were associated with greater risk of all-cause mortality. Our findings demonstrate that reported difficulties are prospectively associated with an increased risk of dementia and all-cause mortality among older people.
KW - geriatric medicine
KW - gerontology
KW - insomnia
KW - sleep difficulties
KW - sleep medicine
UR - http://www.scopus.com/inward/record.url?scp=85107069346&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85107069346&partnerID=8YFLogxK
U2 - 10.1111/jsr.13395
DO - 10.1111/jsr.13395
M3 - Article
C2 - 34080234
AN - SCOPUS:85107069346
SN - 0962-1105
VL - 30
JO - Journal of Sleep Research
JF - Journal of Sleep Research
IS - 6
M1 - e13395
ER -